Damora Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Damora Therapeutics Inc.
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
/ 
Others were interested in
Frequently asked questions
To buy Damora Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Damora Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Damora Therapeutics Inc. is DMRA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Damora Therapeutics Inc. has its primary listing on NASDAQ. You can trade Damora Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Damora Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Damora Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Damora Therapeutics Inc. or others.